Form D · Biotechnology
VERALIGHT INC
Albuquerque, NM · CIK 0001372869
Offering snapshot reported Dec 19, 2012 · SEC filing
- Reported sold
- $200K Offering amount: $213K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 7, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 19, 2012 | Initial | $200,000 | No comparison | 5 | SEC filing |
| Jun 12, 2012 | Initial | $2,533,333 | No comparison | 12 | SEC filing |
| Aug 3, 2011 | Initial | $5,060,702 | No comparison | 12 | SEC filing |
| Jun 6, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 14, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-188654
Amounts listed under Total Offering Amount and Total Amount Remaining to be Sold include an aggregate of $13,333 receivable by the Issuer upon exercise of warrants to purchase shares of the Issuer's Preferred Stock. Such warrants have not been exercised.
Source: Form D, filed Dec 19, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Collier | Director |
| Mike Connolly | Director |
| Lisa Dunlea | Director |
| John Feilders | Director |
| Sumeet Jain | Director |
| John Maynard | Director |
| Joseph Riley | Director |
| M. Ries Robinson | Executive |
| Lisa Suennen | Director |
| Karen Talmadge | Director |
| David Van Avermaete | Director, Executive |
| Albert Waxman | Director |
| James Woodburn | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
800 Bradbury Se, Suite 217
Albuquerque, NM, 87106
Albuquerque, NM, 87106